Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 2 (2006), Issue 9 (September)

1. Proteomic profiling in musculoskeletal oncology by MALDI mass spectrometry.
   Clin Orthop Relat Res, 450: 105-10. [Abstract] [Full-text]
2. A meta-analysis of the effects of psychological interventions in pediatric oncology on outcomes of psychological distress and adjustment.
   J Pediatr Psychol, 31(9): 978-88. [Abstract] [Full-text]
3. Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.
   Oncol Nurs Forum, 33(5): 951-9. [Abstract] [Full-text]
4. Immune globulin IV therapy: optimizing care of patients in the oncology setting.
   Oncol Nurs Forum, 33(5): 911-21. [Abstract] [Full-text]
5. The autopsy in pediatrics and pediatric oncology: a single-institution experience.
   Pediatr Dev Pathol, 9(5): 374-80. [Abstract] [Full-text]
6. The patient's role in the decision-making process--a perspective from the Liverpool Ocular Oncology Centre.
   Eye, 20(9): 1034-9. [Abstract] [Full-text]
7. Feasibility of laparoscopic extraperitoneal surgical staging for locally advanced cervical carcinoma in a gynecologic oncology fellowship training program.
   J Minim Invasive Gynecol, 13(5): 391-7. [Abstract] [Full-text]
8. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients.
   Clin Microbiol Infect, 12(10): 986-91. [Abstract] [Full-text]
9. Denis Burkitt and his contribution to haematology/oncology.
   Br J Haematol, 135(1): 17-25. [Abstract] [Full-text]
10. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200.
    Ann Oncol, 17(9): 1399-1403. [Abstract] [Full-text]
11. Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network.
    Ann Oncol, 17(9): 1418-23. [Abstract] [Full-text]
12. Pediatric medical traumatic stress in pediatric oncology: family systems interventions.
    Curr Opin Pediatr, 18(5): 558-62. [Abstract] [Full-text]
13. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting.
    Eur J Cancer Care (Engl), 15(4): 342-7. [Abstract] [Full-text]
14. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: a report from the Korean society of pediatric hematology-oncology.
    Ann Hematol, 85(11): 787-94. [Abstract] [Full-text]
15. Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.
    Pediatr Blood Cancer, 47(6): 790-4. [Abstract] [Full-text]
16. Tumor model for laparoscopy in pediatric oncology: subperitoneal inoculation of human hepatoblastoma cells in nude rats.
    Eur J Pediatr Surg, 16(4): 231-4. [Abstract] [Full-text]
17. Radioimmunotherapy in a radiation oncology environment: building a multi-specialty team.
    Int J Radiat Oncol Biol Phys, 66(2): S4-6. [Abstract] [Full-text]
18. Iodine-131 tositumomab (Bexxar) in a radiation oncology environment.
    Int J Radiat Oncol Biol Phys, 66(2): S30-4. [Abstract] [Full-text]
19. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
    Gynecol Oncol, 102(3): 432-9. [Abstract] [Full-text]
20. Patients' decision-making process regarding participation in phase I oncology research.
    J Clin Oncol, 24(27): 4479-84. [Abstract] [Full-text]
21. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer.
    Acta Oncol, 45(7): 779-86. [Abstract] [Full-text]
22. Patient satisfaction in radiation oncology.
    Australas Radiol, 50(5): 455-62. [Abstract] [Full-text]
23. Clinical value of image-guided fine needle aspiration of retroperitoneal masses and lymph nodes in gynecologic oncology.
    Gynecol Oncol, 103(1): 75-80. [Abstract] [Full-text]
24. Maternal supplement, micronutrient, and cured meat intake during pregnancy and risk of medulloblastoma during childhood: a children's oncology group study.
    Cancer Epidemiol Biomarkers Prev, 15(9): 1660-7. [Abstract] [Full-text]
25. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital.
    J Oncol Pharm Pract, 12(2): 75-81. [Abstract] [Full-text]
26. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
    Cancer, 107(6): 1280-6. [Abstract] [Full-text]
27. The clinical significance of quality of life assessments in oncology: a summary for clinicians.
    Support Care Cancer, 14(10): 988-98. [Abstract] [Full-text]
28. Calibration of a TLD-100 powder dosimetric system to verify the absorbed dose to water imparted by 137Cs sources in low dose rate brachytherapy at the oncology unit in the Hospital General de Mexico.
    Radiat Prot Dosimetry, 120(1): 95-9. [Abstract] [Full-text]
29. Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05).
    Radiother Oncol, 80(3): 318-22. [Abstract] [Full-text]
30. In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.
    Clin Cancer Res, 12(18): 5454-63. [Abstract] [Full-text]
31. MR in oncology drug development.
    NMR Biomed, 19(6): 681-9. [Abstract] [Full-text]
32. Failure of viridans group streptococci causing bacteremia in pediatric oncology patients to express superantigens.
    J Pediatr Hematol Oncol, 28(9): 627-9. [Abstract] [Full-text]
33. Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.
    Ann Oncol, 17(10): 1560-7. [Abstract] [Full-text]
34. Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.
    J Clin Oncol, 24(28): 4553-7. [Abstract] [Full-text]
35. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    J Clin Oncol, 24(28): 4545-52. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.